See below for the miraculous story of one of Dr. Butterfield’s Spinal Muscular Atrophy patients who received groundbreaking gene therapy replacement therapy through one of our clinical trials!
On Friday, July 31, at 1:00 p.m. ET/12:00 p.m. CT/11:00 a.m. MT/10:00 a.m. PT, Cure SMA will hold its next COVID-19 SMA Community Webinar (watch the March 27 webinar here and the May 28 webinar here). We would like to continue to be a resource for the entire SMA community as we manage the daily challenges of…
Genetic Medicine: A Changing Landscape for Treatment of Spinal Muscular Atrophy (Department of Pediatrics), 17 January 2019
Every month, the Primary Children’s Hospital Department of Pediatrics hosts a lecture series titled the “Pediatric Grand Rounds”. The Pediatric Grand Rounds provide a space for experts in the field of medicine to present on topics pertaining to their work in the field, research, and academic study. On January 17, 2019, Doctor Butterfield was invited…
The University of Utah and The Utah Program for Inherited Neuromuscular Disorders (UPIN) are announced as one of the 26 sites across 13 countries to be conducting the AveXis SMA trial with pre-symptomatic SMA Types 1, 2, and 3 patients. Read more about the trial and the first patient dosed HERE.
UPIN was one of the first centers to join the SMA Care Center Network. This press release describes the network itself and includes a short list of the inaugural centers. Click HERE for the full press release.
All Utah Newborns Now Tested for Spinal Muscular Atrophy (Utah Department of Health), 31 January 2018
Dr. Russell Butterfield comments on the addition of SMA (Spinal Muscular Atrophy) to the newborn screening panel by the Utah Department of Health. An advancement that will provide families with the opportunity to begin treatment proactively. Access the full news feature HERE.